I agree that this site is using cookies. You can find further informations here.
X
IRVING, P
3414  results:
Search for persons X
?
1

P1072 Upadacitinib appears effective in inducing clinical, ..:

Choon, X Y ; Patel, C ; White, C...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1926-i1926 , 2024
Link: https://doi.org/10.1093/..
 
?
2

DOP10 Risankizumab Versus Ustekinumab for the Achievement o..:

Peyrin-Biroulet, L ; Bossuyt, P ; Regueiro, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i90-i91 , 2024
Link: https://doi.org/10.1093/..
 
?
3

P870 Effectiveness and safety of adalimumab as first line b..:

López Cardona, J ; Sharma, E ; Lal, N...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1607-i1608 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P766 No difference in progression of disability 2 years aft..:

Vieujean, S ; Desseaux, K ; Laharie, D...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1429-i1431 , 2024
Link: https://doi.org/10.1093/..
 
?
5

OP01 PROFILE: a multi-centre, randomised, open-label, bioma..:

Noor, N ; Lee, J ; Bond, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1-i2 , 2024
Link: https://doi.org/10.1093/..
 
?
6

P978 Changing therapy to achieve endoscopic healing in asym..:

Systrom, H ; Rai, V ; Singh, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1773-i1773 , 2024
Link: https://doi.org/10.1093/..
 
?
7

P984 VEST: The UK vedolizumab real life experience study in..:

Bodger, K ; Booker, C ; Kok, K...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1784-i1786 , 2024
Link: https://doi.org/10.1093/..
 
?
8

P491 Efficacy and safety of upadacitinib for the treatment ..:

Colombel, J F ; Irving, P ; Rieder, F...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i620-i623 , 2023
Link: https://doi.org/10.1093/..
 
?
9

P535 COVID-19 vaccine-induced neutralising antibody respons..:

Liu, Z ; Alexander, J ; Le, K...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i664-i664 , 2023
Link: https://doi.org/10.1093/..
 
?
10

P034 A common IL2RA polymorphism alters natural killer cell..:

Clough, J ; Roberts, L ; Goldberg, R..
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i200-i201 , 2023
Link: https://doi.org/10.1093/..
 
?
11

P476 Characterization of cardiac conduction abnormalities r..:

Vermeire, S ; Yarur, A ; Rubin, D T...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i604-i606 , 2023
Link: https://doi.org/10.1093/..
 
?
12

P548 Efficacy outcomes of placebo maintenance treatment in ..:

Atreya, R ; Irving, P ; Fujiya, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i675-i677 , 2023
Link: https://doi.org/10.1093/..
 
?
13

P609 Significant variations in practice in managing mild-Cr..:

Dart, R ; Irving, P
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i539-i540 , 2022
Link: https://doi.org/10.1093/..
 
?
14

P554 Vedolizumab Associated quality of Life and inflammator..:

Lim, S ; Gros Alcade, B ; Lehmann, A...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i499-i500 , 2022
Link: https://doi.org/10.1093/..
 
?
15

P430 Longer-term tofacitinib effectiveness for the treatmen..:

Honap, S ; Sharma, E ; Ray, S...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i414-i415 , 2022
Link: https://doi.org/10.1093/..
 
1-15